Brain+ A/S, a healthtech company, develops and commercializes technology solutions in dementia care primarily for cognitive stimulation therapy. The company is developing Ayla, a scalable dementia care platform that offers practical, human-centered, and clinically proven software-based dementia therapy and care solutions. It is also developing Ayla – your CST Assistant, a software-based dementia care platform that offers high-quality and scalable cognitive stimulation therapy (CST). The company offers its products to healthcare providers, as well as patients and carers. Brain+ A/S was incorporated in 2012 and is based in Copenhagen, Denmark.
Metrics to compare | BRAINP | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship RelationshipBRAINPPeersSector | |
---|---|---|---|---|
P/E Ratio | −1.1x | −3.0x | −0.7x | |
PEG Ratio | - | −0.01 | 0.00 | |
Price/Book | 1.0x | 1.7x | 2.6x | |
Price / LTM Sales | 2.5x | 1.4x | 3.4x | |
Upside (Analyst Target) | - | 36.9% | 35.5% | |
Fair Value Upside | Unlock | −0.6% | 3.3% | Unlock |